spacer
home > epc > winter 2002 > the outlook for central nervous system drug development
PUBLICATIONS
European Pharmaceutical Contractor

The Outlook for Central Nervous System Drug Development

t is estimated that as many as 1.5 billion people worldwide are suffering at any given time from some type of central nervous system (CNS) disorder and therefore there is a strong demand from patients for effective treatments (1). In 2001, global sales of CNS products reached US$43 billion, an increase of 17% over the previous year (2). This represented the highest increase of all the top therapeutic categories (2). Pharmaceutical companies have taken note of the demand for CNS medicines and have invested heavily in this area. However, progress in developing new treatments for these complex disorders is dependent on identifying the relevant factors to each disorder and many of these disorders are still poorly understood (1).

The Health Burden of CNS Disorders

Studies by the World Health Organization (WHO) have shown that the impact of CNS disorders on society has been seriously underestimated by traditional health care approaches, as these focused on deaths and not disability (1, 3). In the 1990s, WHO global figures revealed that CNS conditions accounted for 28% of all years lived with a disability (YLDs) compared with 1.4% of all deaths and 1.1% of years of life lost (1, 3). The predominance of these conditions is not just restricted to the most developed countries and therefore there is a global demand for effective medicines treating CNS disorders.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer
By Dr Faiz Kermani, Budgets, Proposals and Marketing Executive, and Stuart McGuire, Business Development Executive at Chiltern International

Dr Faiz Kermani currently works in Business Development at Chiltern International, a CRO, where his role covers bids, proposals and marketing. Previously, Faiz worked in Business Development at CMR International, examining R&D productivity issues for pharmaceutical industry clients. He has also worked as a research analyst for Danish health care consultancy Informedica A/S, focusing on global pharmaceutical pricing and parallel importation.

He holds a PhD in immunopharmacology from St. Thomas' Hospital in London and a First Class Honours Degree in Pharmacology with Toxicology from King's College, London. .

Stuart McGuire has worked as a Business Development Executive at Chiltern International for two years.

After graduating in Chemistry from the University of Surrey in 1999, he worked in malaria research before moving into marketing. One of Stuart's current areas of interest at Chiltern is R&D within the Japanese pharmaceutical industry.



spacer
Dr Faiz Kermani
spacer
spacer
spacer
Stuart McGuire
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Paediatric Clinical Trials

21-22 March 2012, Copthorne Tara Hotel, London, United Kingdom

Designing accurate and safe paediatric formulations is one of the topics being discussed at SMi’s Paediatric Clinical Trials held on 21st & 22nd March 2012
More info >>

 
News and Press Releases

Firstan Ltd are first to achieve the new Pharmaceutical PS9000:2011 quality standard

Firstan Ltd, the UK’s leading independently owned Pharmaceutical and Food Carton producer have become the first UK Packaging company to achieve the new Pharmaceutical PS9000:2011 quality standard for its Healthcare Division. This standard was published in September 2011 in consultation with industry suppliers, pharmaceutical companies and other stakeholder organisations. Firstan have held the Pharmaceutical accreditation for almost 20 years.  
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.